Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Jun 15
Love0

Racial Disparities in Primary Therapy for Newly Diagnosed Psoriasis Patients

By Chuck Lin No Comments
To the Editor:  Psoriasis treatments have been shown to vary by race, but racial differences in initial psoriasis treatment has not been adequately studied.1,2 Our objectives were to compare the…
Read More
Jun 15
Love0

Barriers to Dermatologic Care and Use of Internet Sources in Hidradenitis Suppurativa

By Chuck Lin No Comments
INTRODUCTIONAlthough hidradenitis suppurativa (HS) often requires multidisciplinary care, dermatologists specialize in the diagnosis and management of this condition. As HS is associated with low socioeconomic status, individuals may face barriers…
Read More
Jun 14
Love0

Erythrodermic Bullous Pemphigoid in Skin of Color Treated With Dupilumab

By Chuck Lin No Comments
CASE REPORTAn African American male in his 80s with a past medical history of atrial fibrillation, congestive heart failure, type 2 diabetes mellitus, hypertension, prostate cancer, chronic kidney disease, and…
Read More
Jun 14
Love0

Poroma in a Patient With Fitzpatrick Type V Skin

By Chuck Lin No Comments
CASEAn 82-year-old African American male (Fitzpatrick Type V) presented with a tender, bleeding exophytic growth on the right lateral foot enlarging over the preceding three months. Examination showed a 0.9…
Read More
Jun 13
Love0

From the Community to Capitol Hill

By Chuck Lin No Comments
Dear Editor: Telemedicine has increasingly gained more attention and use since the onset of the pandemic as quality healthcare can be delivered at a distance, reach underserved populations, decrease the…
Read More
Jun 13
Love0

Minimizing Bias in Alopecia Diagnosis in Skin of Color Patients

By Chuck Lin No Comments
INTRODUCTIONAlopecia is one of the most common dermatologic conditions affecting Black patients, with a significantly negative impact on quality of life.1,2 Timely and accurate diagnosis is therefore critical in order…
Read More
Jun 07
Love0

Dermatologist Practical Guide to Encouraging Photoprotection in Skin of Color Patients

By Chuck Lin No Comments
INTRODUCTIONPatients with skin of color (SOC) are at risk for skin cancers and photoaging and have a unique predisposition to pigmentary disorders that are exacerbated by ultraviolet light exposure. Sun…
Read More
Jun 06
Love0

Scarring and Dyschromias in Fitzpatrick Skin Type IV-VI: A Review of Dermatologic Treatment Protocols

By Chuck Lin No Comments
INTRODUCTIONAs with much of dermatology, most research on wound healing has been based on afflictions in light skin, resulting in a dearth of evidence-based protocols on the management of wound…
Read More
May 31
Love0

FULL SUPPLEMENT: Clascoterone Cream 1%: Mechanism of Action, Efficacy, and Safety of a Novel, First-in-Class Topical Antiandrogen Therapy for Acne

By Chuck Lin No Comments
In this supplement: Clascoterone Cream 1%: Mechanism of Action, Efficacy, and Safety of a Novel, First-in-Class Topical Antiandrogen Therapy for Acne  Acne is a prevalent chronic inflammatory disease that causes…
Read More
May 31
Love0

Individual Article: Clascoterone Cream 1%: Mechanism of Action, Efficacy, and Safety of a Novel, First-in-Class Topical Antiandrogen Therapy for Acne

By Chuck Lin No Comments
INTRODUCTIONAcne is a prevalent chronic inflammatory disease that causes both severe psychiatric effects and physical scarring of the skin.1-4 The 4 pathogenetic pathways that contribute to this condition are increased…
Read More
May 31
Love0

Reduction of Erythema in Moderate-Severe Rosacea by a Low Molecular Weight Heparan Sulfate Analog (HSA)

By Chuck Lin No Comments
INTRODUCTIONRosacea is a chronic inflammatory skin condition that affects blood vessels and pilosebaceous units.1 It is characterized by recurrent flushing, telangiectasia, central facial erythema, and papules/pustules that often present on…
Read More
May 25
Love0

The Many Faces of Pediatric Acne: A Practical Algorithm for Treatment, Maintenance Therapy, and Skincare Recommendations for Pediatric Acne Patients

By Chuck Lin No Comments
INTRODUCTIONAcne vulgaris (acne) is a multifactorial skin disease with a prolonged course of acute outbreaks, relapses, and recurrences with significant social, psychological, and physical consequences.1-6 The presentation of pediatric acne…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • JDD in the News: Topical Nonsteroidals for Chronic Hand Eczema May 30, 2026
  • Efficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study May 29, 2026
  • Longer Pembrolizumab Therapy Reduces Mortality in Stage III and IV Melanoma: A TriNetX Study May 28, 2026
  • Clinical Methodology to Evaluate the Efficacy of a Topical Cosmetic Eye Formulation on the Appearance of Dynamic Periorbital Lines May 27, 2026
  • Safety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ May 26, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference LVD        PDE       

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram